Literature DB >> 12543477

Estrogen enhances potassium-stimulated acetylcholine release in the rat hippocampus.

Rachel Gabor1, Rajesh Nagle, David A Johnson, Robert B Gibbs.   

Abstract

Short-term estrogen replacement has been shown to enhance basal forebrain cholinergic function. Whether or not long-term estrogen replacement can enhance basal forebrain cholinergic function has been questioned in light of recent studies showing that several cholinergic measures which are increased following short-term treatment are not increased following longer-term (>30 days) treatment. In the present study, in vivo microdialysis was used to assess the effects of continuous estradiol replacement on basal forebrain cholinergic function. Our data show that 6-7 weeks of continuous estradiol replacement significantly enhanced potassium-stimulated acetylcholine release in the hippocampus of ovariectomized rats, and that this effect was reversed following discontinuation of the estrogen treatment. These data are consistent with the hypothesis that estrogen-mediated effects on cholinergic neurons can contribute to the effects of long-term estrogen replacement on cognitive performance recently described.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12543477     DOI: 10.1016/s0006-8993(02)04053-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  16 in total

1.  The α7 nicotinic acetylcholine receptors regulate hippocampal adult-neurogenesis in a sexually dimorphic fashion.

Authors:  Simone L Otto; Jerrel L Yakel
Journal:  Brain Struct Funct       Date:  2018-12-04       Impact factor: 3.270

Review 2.  Estrogen, menopause, and the aging brain: how basic neuroscience can inform hormone therapy in women.

Authors:  John H Morrison; Roberta D Brinton; Peter J Schmidt; Andrea C Gore
Journal:  J Neurosci       Date:  2006-10-11       Impact factor: 6.167

3.  Reduced Chrna7 expression in mice is associated with decreases in hippocampal markers of inhibitory function: implications for neuropsychiatric diseases.

Authors:  C E Adams; J C Yonchek; K M Schulz; S L Graw; J Stitzel; P U Teschke; K E Stevens
Journal:  Neuroscience       Date:  2012-01-25       Impact factor: 3.590

4.  Galanthamine plus estradiol treatment enhances cognitive performance in aged ovariectomized rats.

Authors:  R B Gibbs; A M Chipman; R Hammond; D Nelson
Journal:  Horm Behav       Date:  2011-08-26       Impact factor: 3.587

5.  Chronic treatment with a GPR30 antagonist impairs acquisition of a spatial learning task in young female rats.

Authors:  R Hammond; D Nelson; E Kline; R B Gibbs
Journal:  Horm Behav       Date:  2012-07-22       Impact factor: 3.587

6.  Estradiol-induced increase in the magnitude of long-term potentiation is prevented by blocking NR2B-containing receptors.

Authors:  Caroline C Smith; Lori L McMahon
Journal:  J Neurosci       Date:  2006-08-16       Impact factor: 6.167

7.  Role of GPR30 in mediating estradiol effects on acetylcholine release in the hippocampus.

Authors:  R B Gibbs; D Nelson; R Hammond
Journal:  Horm Behav       Date:  2014-06-11       Impact factor: 3.587

Review 8.  Long-term consequences of estrogens administered in midlife on female cognitive aging.

Authors:  Jill M Daniel; Christine F Witty; Shaefali P Rodgers
Journal:  Horm Behav       Date:  2015-04-25       Impact factor: 3.587

Review 9.  Estrogen therapy and cognition: a review of the cholinergic hypothesis.

Authors:  Robert B Gibbs
Journal:  Endocr Rev       Date:  2009-12-17       Impact factor: 19.871

10.  Estrogen effects on high-affinity choline uptake in primary cultures of rat basal forebrain.

Authors:  Katie M Bennett; Courtney Hoelting; Christopher P Martin; James Stoll
Journal:  Neurochem Res       Date:  2008-05-16       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.